CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jeil Pharmaceutical Company Limited Company Snapshot
Jeil Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jeil Pharmaceutical Company Limited with three other companies in this sector in South Korea: Hanmi Science Company Limited (2016 sales of 665.28 billion Korean Won [US$591.44 million] of which 96% was Pharmaceutical Sales), Dong-A Socio Holdings Co Ltd (726.17 billion Korean Won [US$645.56 million] of which 67% was Pharmaceutication), and Dong A St Co Ltd (560.54 billion Korean Won [US$498.32 million] ).

Sales Analysis. Jeil Pharmaceutical Company Limited reported sales of 617.28 billion Korean Won (US$548.76 million) for the year ending December of 2016. This represents an increase of 3.8% versus 2015, when the company's sales were 594.72 billion Korean Won. This was the fourth straight year of sales growth at Jeil Pharmaceutical Company Limited.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jeil Pharmaceutical Company Limited
  Stock Performance Chart for Jeil Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 81,600
(Figures in Korean Won)
1 Week 10.0%   13 Weeks 23.6%  
4 Weeks 12.1%   52 Weeks -20.8%  
 
Jeil Pharmaceutical Company Limited Key Data:
  Ticker: 002620 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 617,279,879,535
(Year Ending Jan 2017).
Employees: 1,087
  Currency: Korean Won Market Cap: 1,039,268,779,200
  Fiscal Yr Ends: December Shares Outstanding: 12,736,137
  Share Type: Common Closely Held Shares: 6,832,050
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.